Abstract

pVHL (von Hippel-Lindau tumor suppressor protein) is the substrate recognition subunit of the CBC(VHL) ubiquitin ligase complex promoting the degradation of hypoxia-inducible factor subunits, HIF-1/2alpha. Mutational inactivation of pVHL causes the hereditary von Hippel-Lindau tumor syndrome, which predisposes affected individuals to hemangioblastomas, renal cell carcinomas, and pheochromocytomas. Whereas the development of hemangioblastomas and renal cell carcinomas has been attributed to impaired HIF-1/2alpha down-regulation by pVHL mutant proteins, the molecular defects underlying the development of pheochromocytomas are still unknown. Here, we present a detailed biochemical analysis of pVHL mutant proteins linked to type 2C (pheochromocytoma only) von Hippel-Lindau disease. Type 2C-associated mutations caused extensive structural perturbations of pVHL, as revealed by the reduced stability, increased proteolytic susceptibility, and dramatically altered NMR spectrum of recombinant, mutant pVHL-ElonginC-ElonginB complexes in vitro. In human cell lines, type 2C-linked mutations destabilized the CBC(VHL) ubiquitin ligase complex and resulted in reduced cellular pVHL levels. Together, our data reveal unexpectedly strong structural defects of type 2C-associated pVHL mutant proteins that are likely to affect both HIF-1/2alpha-related and -unrelated pVHL functions in the pathogenesis of pheochromocytomas.

Highlights

  • Von Hippel-Lindau disease (OMIM 193300) is an autosomal dominant, hereditary cancer syndrome caused by germ line mutations in the VHL tumor suppressor gene [1, 2]

  • Type 1-associated pVHL mutant proteins fail to assemble into a functional CBCVHL E3 ubiquitin ligase complex [14], whereas type 2Aand type 2B-associated pVHL mutant proteins were shown to be differentially affected in HIF-1/2␣ binding [15,16,17]

  • We show that type 2C-associated pVHL mutant proteins are mildly defective in HIF-1␣ regulation, suggesting the possibility that a low level of HIF-1/2␣ dysregulation contributes to the pathogenesis of pheochromocytomas

Read more

Summary

EXPERIMENTAL PROCEDURES

Plasmids—pVB and pBB75 [14], pST39-HisTrxN-VHLElonginB-ElonginC [39], and pcDNA3-HA-VHL [23] were gifts of N. RCC4-derived cell pools expressing wild type or mutant VHL were generated by infection with retroviruses obtained by transfecting LinX-A cells with pBabe-Puro-VHL using FuGENE (Roche Applied Science). Stable cell pools were selected and maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum, 100 units/ml penicillin, 100 ␮g/ml streptomycin, and 2 ␮g/ml puromycin. Protein Purification—Expression and purification of recombinant VCB complex were performed exactly as described [15]. For isotopically enriched protein preparations, VCB or ElonginBC complexes were co-expressed in minimal medium containing 15NH4Cl and purified as will be published elsewhere.. Protein levels in RCC4-derived cell pools were analyzed by immunoblots using antibodies directed against pVHL Quantitative PCR—To quantify mRNA levels in RCC4-derived cell pools, total RNA from 106 cells was purified using a High Pure RNA isolation kit (Roche Applied Science).

Substrate binding of wild type and mutant VCB complexes
Kd koff kona
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.